Literature DB >> 21078716

Progressive loss of lymphatic vessels in skin of patients with systemic sclerosis.

Mirko Manetti1, Anna Franca Milia, Serena Guiducci, Eloisa Romano, Marco Matucci-Cerinic, Lidia Ibba-Manneschi.   

Abstract

OBJECTIVE: Systemic sclerosis (SSc) is a connective tissue disorder characterized by microvascular and fibrotic changes in the skin and internal organs. The role of blood vessel dysfunction in the pathogenesis of SSc has been extensively investigated, but few studies have addressed the involvement of the lymphatic vascular system. Our aim was to evaluate dermal lymphatic vessels in patients with SSc according to different phases of skin involvement.
METHODS: Skin biopsies were obtained from the forearm of 25 SSc patients (10 early/15 late-stage disease) and 13 healthy controls. Skin sections were immunostained for podoplanin (D2-40), which is selectively expressed in lymphatic endothelial cells, and examined by confocal laser scanning microscopy. Lymphatic vessels were counted in the papillary and reticular dermis. Data were analyzed using Student's t test.
RESULTS: The number of lymphatic vessels was significantly reduced in the papillary and reticular dermis of SSc patients compared with controls. In early SSc, lymphatic vessel counts were not different from controls in the papillary dermis, and showed a trend toward a reduction in the reticular dermis. In late SSc, a significant reduction in lymphatic vessels compared with controls was found in both the papillary and reticular dermis. The number of lymphatic vessels in the papillary dermis of late SSc was significantly lower than in early SSc.
CONCLUSION: In SSc, lymphatic microangiopathy is linked to the progression of skin involvement. The progressive disappearance of lymphatic vessels may have a critical pathogenetic role in the progression of SSc from an early edematous phase to overt fibrosis.

Entities:  

Mesh:

Year:  2010        PMID: 21078716     DOI: 10.3899/jrheum.100767

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

1.  Lymphedema secondary to limited cutaneous systemic sclerosis.

Authors:  Sónia Moreira; Jorge Crespo; Lèlita Santos
Journal:  BMJ Case Rep       Date:  2018-06-15

2.  Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90.

Authors:  Banafsheh Nazari; Lisa M Rice; Giuseppina Stifano; Alexander M S Barron; Yu Mei Wang; Tess Korndorf; Jungeun Lee; Jag Bhawan; Robert Lafyatis; Jeffrey L Browning
Journal:  Am J Pathol       Date:  2016-08-23       Impact factor: 4.307

3.  Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.

Authors:  Allison L Mathes; Romy B Christmann; Giuseppina Stifano; Alsya J Affandi; Timothy R D J Radstake; G Alessandra Farina; Cristina Padilla; Sarah McLaughlin; Robert Lafyatis
Journal:  Ann Rheum Dis       Date:  2013-07-19       Impact factor: 19.103

Review 4.  Lymphatic Function in Autoimmune Diseases.

Authors:  Noa Schwartz; Madhavi Latha S Chalasani; Thomas M Li; Zhonghui Feng; William D Shipman; Theresa T Lu
Journal:  Front Immunol       Date:  2019-03-20       Impact factor: 7.561

5.  Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence.

Authors:  Mirko Manetti; Eloisa Romano; Irene Rosa; Bianca Saveria Fioretto; Serena Guiducci; Silvia Bellando-Randone; Erika Pigatto; Franco Cozzi; Lidia Ibba-Manneschi; Marco Matucci-Cerinic
Journal:  Int J Mol Sci       Date:  2019-12-07       Impact factor: 5.923

6.  Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis.

Authors:  Mirko Manetti; Serena Guiducci; Martina Ruffo; Irene Rosa; Maria Simonetta Faussone-Pellegrini; Marco Matucci-Cerinic; Lidia Ibba-Manneschi
Journal:  J Cell Mol Med       Date:  2013-02-27       Impact factor: 5.310

7.  Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations.

Authors:  Vishalakshi Viswanath; Meghana M Phiske; Vinay V Gopalani
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

8.  Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide.

Authors:  Marilisa Villano; Annalisa Borghini; Mirko Manetti; Erica Gabbrielli; Antonella Rossi; Piersante Sestini; Anna Milia; Francesca Nacci; Serena Guiducci; Marco Matucci-Cerinic; Lidia Ibba-Manneschi; Elisabetta Weber
Journal:  Arthritis Res Ther       Date:  2013-08-20       Impact factor: 5.156

9.  Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome.

Authors:  Alessia Alunno; Lidia Ibba-Manneschi; Onelia Bistoni; Irene Rosa; Sara Caterbi; Roberto Gerli; Mirko Manetti
Journal:  J Cell Mol Med       Date:  2016-02-01       Impact factor: 5.310

Review 10.  Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?

Authors:  Cosimo Bruni; Tracy Frech; Mirko Manetti; Francesca Wanda Rossi; Daniel E Furst; Amato De Paulis; Felice Rivellese; Serena Guiducci; Marco Matucci-Cerinic; Silvia Bellando-Randone
Journal:  Front Immunol       Date:  2018-09-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.